McChip Resources Inc. (MCCHF)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6	3	3	3	3	2
Market Cap Growth	-35.49%	-5.21%	-20.87%	13.64%	24.58%	5.78%
Enterprise Value	-1	-3	-2	-1	-1	-1
Last Close Price	0.44	0.42	0.39	0.45	0.55	0.30
PE Ratio	2.91	1.22	6.19	-	3.01	1.68
PS Ratio	2.20	0.92	2.48	15.59	1.76	1.25
PB Ratio	0.83	0.34	0.42	0.56	0.43	0.41
P/TBV Ratio	0.83	0.34	0.42	0.56	0.43	0.41
P/OCF Ratio	7.80	17.23	-	32.00	22.74	54.29
Debt / Equity Ratio	0.00	0.17	0.22	0.20	0.10	0.09
Debt / EBITDA Ratio	0.00	0.58	2.95	-	0.66	0.36
Asset Turnover	0.38	0.34	0.14	0.03	0.24	0.32
Quick Ratio	36.70	5.64	4.45	5.02	8.14	8.48
Current Ratio	37.08	5.70	4.50	5.08	8.21	8.54
Return on Equity (ROE)	32.49%	31.10%	6.92%	-4.50%	15.45%	27.51%
Return on Assets (ROA)	18.37%	16.35%	3.49%	-2.80%	8.65%	14.23%
Return on Capital (ROIC)	18.90%	16.80%	3.58%	-2.86%	8.85%	14.62%
Return on Capital Employed (ROCE)	28.90%	28.20%	6.80%	-	14.30%	23.50%
Earnings Yield	34.32%	81.79%	16.17%	-8.30%	33.26%	59.70%
Dividend Yield	7.91%	14.89%	11.58%	6.50%	5.80%	5.16%
Payout Ratio	9.26%	17.47%	60.84%	-	18.34%	6.32%
Buyback Yield / Dilution	-	-	-	-0.37%	-0.48%	0.59%
Total Shareholder Return	7.91%	14.89%	11.58%	6.14%	5.32%	5.75%

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.